- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes Dyslipidemia
Authors
Keywords
Cardiovascular risk, Diabetes, Dyslipidemia, Lipoproteins, Low density lipoprotein cholesterol
Journal
Diabetes Therapy
Volume 7, Issue 2, Pages 203-219
Publisher
Springer Nature
Online
2016-04-07
DOI
10.1007/s13300-016-0167-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell ProtectionSignificance
- (2016) Jonas W. Brinck et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis
- (2016) Bernard Zinman et al. Canadian Journal of Diabetes
- Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up
- (2016) DIABETES CARE
- Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data
- (2016) Naveed Sattar et al. Lancet Diabetes & Endocrinology
- Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology
- (2015) Viveca Gyberg et al. Cardiovascular Diabetology
- Unintended positive and negative effects of drugs on lipoproteins
- (2015) Tarza J. Siahmansur et al. CURRENT OPINION IN LIPIDOLOGY
- Pathophysiology of diabetic dyslipidaemia: where are we?
- (2015) Bruno Vergès DIABETOLOGIA
- Saroglitazar for the treatment of dyslipidemia in diabetic patients
- (2015) Shashank R Joshi EXPERT OPINION ON PHARMACOTHERAPY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- PCSK9 inhibition to reduce cardiovascular disease risk
- (2015) Hagai Tavori et al. Current Opinion in Endocrinology Diabetes and Obesity
- Role for Combination Therapy in Diabetic Dyslipidemia
- (2015) Haider J. Warraich et al. Current Cardiology Reports
- High-density lipoprotein, beta cells, and diabetes
- (2014) A. von Eckardstein et al. CARDIOVASCULAR RESEARCH
- Weight Loss, Glycemic Control, and Cardiovascular Disease Risk Factors in Response to Differential Diet Composition in a Weight Loss Program in Type 2 Diabetes: A Randomized Controlled Trial
- (2014) Cheryl L. Rock et al. DIABETES CARE
- 8. Cardiovascular Disease and Risk Management
- (2014) DIABETES CARE
- Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
- (2014) T. Forst et al. DIABETES OBESITY & METABOLISM
- Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
- (2014) HEART
- A review of paradoxical HDL-C responses to fenofibrate, illustrated by a case report
- (2014) Jonathan D. Schofield et al. Journal of Clinical Lipidology
- Evaluating Second-Line Treatment Options for Type 2 Diabetes: Focus on Secondary Effects of GLP-1 Agonists and DPP-4 Inhibitors
- (2013) Cassie L Boland et al. ANNALS OF PHARMACOTHERAPY
- Prognostic Significance of Silent Myocardial Infarction in Newly Diagnosed Type 2 Diabetes Mellitus
- (2013) Timothy M.E. Davis et al. CIRCULATION
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. CIRCULATION
- Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
- (2013) John M. Lachin et al. DIABETES CARE
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial
- (2013) K. Hermansen et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
- (2013) F. J. Lavalle-González et al. DIABETOLOGIA
- Role of HDL Cholesterol and Estimates of HDL Particle Composition in Future Development of Type 2 Diabetes in the General Population: The PREVEND Study
- (2013) Ali Abbasi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Dapagliflozin on Cardiovascular Risk Factors
- (2013) Agata Ptaszynska et al. POSTGRADUATE MEDICINE
- Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2013) Michael Roden et al. Lancet Diabetes & Endocrinology
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Effects on Lipid Profile of Dipeptidyl Peptidase 4 Inhibitors, Pioglitazone, Acarbose, and Sulfonylureas: Meta-analysis of Placebo-Controlled Trials
- (2012) Matteo Monami et al. ADVANCES IN THERAPY
- New lipid-lowering drugs: an update
- (2012) A. S. Wierzbicki et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
- (2012) European Journal of Preventive Cardiology
- Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study
- (2012) Shona J. Livingstone et al. PLOS MEDICINE
- Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes
- (2011) C. Morgantini et al. DIABETES
- ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
- (2011) et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients
- (2011) H. Soran et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus
- (2010) Eric A. Schwartz et al. ATHEROSCLEROSIS
- Lipid Effects of Endocrine Medications
- (2010) Dan V. Mihailescu et al. Current Atherosclerosis Reports
- Fibrates: no ACCORD on their use in the treatment of dyslipidaemia
- (2010) Anthony S Wierzbicki CURRENT OPINION IN LIPIDOLOGY
- Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication
- (2010) D. M. Maahs et al. DIABETOLOGIA
- Intensified glucose lowering in type 2 diabetes: time for a reappraisal
- (2010) J. S. Yudkin et al. DIABETOLOGIA
- Clinical Predictors of Plaque Progression Despite Very Low Levels of Low-Density Lipoprotein Cholesterol
- (2010) Ozgur Bayturan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
- (2010) Clifford J Bailey et al. LANCET
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults
- (2010) Elizabeth Selvin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Dysfunctional HDL as a Diagnostic and Therapeutic Target
- (2009) Jonathan D. Smith ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
- (2009) Vivian A. Fonseca et al. DIABETES OBESITY & METABOLISM
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
- (2009) Kausik K Ray et al. LANCET
- Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus
- (2009) Takahiro Araki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives
- (2008) William S. Harris et al. ATHEROSCLEROSIS
- Glycation as an atherogenic modification of LDL
- (2008) Nahla Younis et al. CURRENT OPINION IN LIPIDOLOGY
- Statins and diabetes – Authors' reply
- (2008) Patricia M Kearney et al. LANCET
- Paget's Disease of the Mandible
- (2008) Mayank B. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
- (2008) William Duckworth et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started